Collectively, these findings suggest that doxycycline interacts with integrin avβ3 to downregulate ERK1/2 phosphorylation and downstream PD-L1 signaling and gene expression, thereby inhibiting cancer cell growth. The gene discussed is MAPK3; the disease is cancer.